Valuation: Pharmena S.A.

Market Cap 35.08M 9.27M 8.11M 7.48M 6.91M 13.1M 884M 13.32M 89.34M 435M 34.8M 34.04M 1.5B P/E 2024
-33.8x
P/E 2025 -10.4x
Enterprise Value 35.09M 9.27M 8.11M 7.48M 6.91M 13.11M 884M 13.33M 89.36M 436M 34.81M 34.05M 1.5B EV / Sales 2024
154x
EV / Sales 2025 18.4x
Free-Float
29.7%
Yield 2024 *
-
Yield 2025 -
1 day+0.64%
1 week-0.32%
1 month+0.32%
3 months-3.96%
6 months-14.86%
Current year+21.15%
1 week 3.02
Extreme 3.02
3.16
1 month 3.02
Extreme 3.02
3.3
Current year 2.56
Extreme 2.56
4.32
1 year 2.5
Extreme 2.5
4.32
3 years 2.5
Extreme 2.5
9.18
5 years 2.5
Extreme 2.5
13.7
10 years 2.5
Extreme 2.5
33.48
Manager TitleAgeSince
Chief Executive Officer - 12/11/2002
Chief Tech/Sci/R&D Officer - 01/04/2008
Director TitleAgeSince
Director/Board Member 62 -
Director/Board Member 63 -
Chairman 52 25/06/2025
Change 5-day change 1-year change 3-year change Capi.($)
+0.64%-0.32%-10.00%-57.32% 9.27M
+0.36%-0.38%+1.91%-8.03% 233B
-0.89%-3.73%+37.95% - 50.25B
+2.60%-1.96%+125.50% - 9.35B
+1.63%-0.44%+11.11%-56.00% 6.82B
+5.85%+1.57%-7.30%+18.25% 5.07B
+1.31%+0.43%-30.21%-32.93% 4.52B
+0.73%-0.09%-12.05%-11.26% 3.82B
+1.25%-3.66%-30.22%-45.21% 3.34B
+0.63%+0.02%-22.28%-48.98% 2.58B
Average +1.41%-0.60%+6.44%-30.18% 31.83B
Weighted average by Cap. +0.37%-0.90%+10.13%-10.15%

Financials

2024 2025
Net sales 268K 70.79K 61.92K 57.12K 52.75K 100K 6.75M 102K 682K 3.33M 266K 260K 11.43M 1.58M 417K 364K 336K 310K 589K 39.73M 599K 4.02M 19.57M 1.56M 1.53M 67.29M
Net income -1.26M -333K -292K -269K -248K -471K -31.79M -479K -3.21M -15.66M -1.25M -1.22M -53.85M -2.77M -731K -640K -590K -545K -1.03M -69.76M -1.05M -7.05M -34.37M -2.75M -2.69M -118M
Net Debt -1.5M -397K -347K -320K -295K -561K -37.82M -570K -3.82M -18.63M -1.49M -1.46M -64.04M 9K 2.38K 2.08K 1.92K 1.77K 3.36K 227K 3.42K 22.92K 112K 8.93K 8.73K 384K
Logo Pharmena S.A.
Pharmena SA is a Poland-based producer of cosmetics and pharmaceuticals. The Company’s products range encompasses Dermena, a line of products against hair loss; Dermena Plus, a shampoo reducing the symptoms of dandruff and preventing excessive hair loss; Accos, an anti-acne gel; Allerco, a line of hypo-allergic emollients for body care, Thermi, a gel after thermal burn and sunburn; and Revium, a line of anti-wrinkle treatment products. Pharmena SA maintains multidirectional research works and application studies in conjunction with a number of research centers in Europe, the United States and Canada. As of December 31, 2011, the Company had one wholly owned subsidiary, Cortria Corporation, based in the United States. As of December 31, 2011, Polska Grupa Farmaceutyczna SA held a 43.65% stake in the capital. The main shareholder of the Company is Pelion SA.
Employees
7
Date Price Change Volume
10/07/26 PLN 3.150 +0.64% 1,021
09/07/26 PLN 3.130 0.00% 12
08/07/26 PLN 3.130 +2.96% 330
07/07/26 PLN 3.040 -2.88% 3,505
06/07/26 PLN 3.130 -0.95% 1,940